Is the prognosis of heart failure improving?

Journal of the American College of Cardiology

Volumn 36, Issue 7, 2000, Pages 2284-2286

  Khand, Aleem ^a   Gemmel, Islay ^b   Clark, Andrew L ^a   Cleland, John G F ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ECHOCARDIOGRAPHY; HEART FAILURE; HIGH RISK POPULATION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL;

EID: 0033667145     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00995-5     Document Type: Editorial

References (35)

1. Survival after the onset of congestive heart failure in Framingham heart study subjects
2. Survival of patients with a new diagnosis of heart failure: A population based study
3. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
4. Sympathetic activation in heart failure and its treatment with beta blockade
5. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalaptil Survival Study (CONSENSUS)
6. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
7. The cardiac insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
8. Radical alternatives to transplantation
9. The evidence for beta-blockers equals or surpasses that for ACE inhibitors in heart failure
10. Congestive heart failure in the community
11. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction
12. Clinical characteristics and mortality of patients screened for entry into the Trandopril Cardiac Evaluation (TRACE) Study
13. Incidence and aetiology of heart failure: A population-based study
14. The epidemiology of heart failure: The Framingham Study
15. Risk factors for heart failure in the general population: The study of men born in 1913
16. Incidence of heart failure in eastern Finland: A population-based surveillance study
17. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
18. Prevalence, aetiology and management of heart failure in general practice
19. Angiotensin-converting enzyme inhibitors: Are we ignoring the evidence?
20. Has the survival of the heart failure population changed? Lessons from trials
21. The epidemiology of heart failure
22. Prevalence of heart failure in three general practices in north west London
23. Congestive heart failure: Insights from epidemiology, implications for treatment
24. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort
25. Perindopril for elderly people with chronic heart failure: The PEP-CHF study
26. The incidence and prevalence of congestive heart failure in Rochester, Minnesota
27. Candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM): Rationale and design: CHARM-Programme Investigators
28. Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial
29. Evolving trends in the epidemiological factors of heart failure: Rational for preventive strategies and comprehensive disease management
30. Is the prognosis of heart failure improving?
31. Changing patterns of investigation and treatment of cardiac failure in hospital
32. ACE inhibitors for the prevention and treatment of heart failure: Why are they 'underused'?
33. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?
34. Biochemical detection of left ventricular systolic dysfunction
35. Heart Failure: A medical hydra